Patient Factors Lead to Extensive Variation in Outcomes and Cost From Cholecystectomy
Background Cholecystectomy is a common procedure with significantly varied outcomes. We analyzed differences in comorbidities, outcomes, and cost of cholecystectomy by acute care surgery (ACS) versus hepatopancreaticobiliary (HPB) surgery. Study design Patients were retrospectively identified betwee...
Gespeichert in:
Veröffentlicht in: | The American surgeon 2020-06, Vol.86 (6), p.643-651 |
---|---|
Hauptverfasser: | , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 651 |
---|---|
container_issue | 6 |
container_start_page | 643 |
container_title | The American surgeon |
container_volume | 86 |
creator | Baimas-George, Maria Kirks, Russell C. Cochran, Allyson Baker, Erin H. Lauren Paton, B. Schiffern, Lynnette M. Matthews, Brent D. Martinie, John B. Vrochides, Dionisios Iannitti, David A. |
description | Background
Cholecystectomy is a common procedure with significantly varied outcomes. We analyzed differences in comorbidities, outcomes, and cost of cholecystectomy by acute care surgery (ACS) versus hepatopancreaticobiliary (HPB) surgery.
Study design
Patients were retrospectively identified between 2008 and 2015. Exclusion criteria included the following: (1) part of another procedure; (2) abdominal trauma; (3) ICU admission; vasopressors.
Results
One hundred and twenty-six ACS and 122 HPB patients were analyzed. The HPB subset had higher burden of comorbid disease and significantly lower projected 10-year survival (87.4% ACS vs 68.5% HPB, P < .0001). Median lengths of stay were longer in HPB patients (2 vs 5 days, P < .0001) as were readmission rates (30-day 5.6% vs 13.1%, P = .040; 90-day 7.9% vs 20.5%, P = .005). Median cost was higher including operative supply cost ($969.42 vs $1920.66, P < .0001) and total cost of care ($7340.66 vs $19 338.05, P < .0001). A predictive scoring system for difficult gallbladders was constructed and a phone application was created.
Conclusion
Cholecystectomy in a complicated patient can be difficult with longer hospital stays and higher costs. The utilization of procedure codes to explain disparities is not sufficient. Incorporation of comorbidities needs to be addressed for planning and reimbursement. |
doi_str_mv | 10.1177/0003134820923311 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2425589786</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sage_id>10.1177_0003134820923311</sage_id><sourcerecordid>2444866854</sourcerecordid><originalsourceid>FETCH-LOGICAL-c295t-921dd7e67f2c2f143db728a5dd2a07bf06f664901b8fa70c603fa53443ad2df93</originalsourceid><addsrcrecordid>eNp1kE1LAzEYhIMoWKt3jwEvXlbznd2jLK0KhXqwXpc0H7pld1OTrNh_b0oFoeDpZZhnhpcB4BqjO4ylvEcIUUxZSVBFKMX4BEww57yoSkJPwWRvF3v_HFzEuMmSCY4nYPWiUmuHBOdKJx8iXFhlYPJw9p3sENsvC99UaDPkB9gOcDkm7XsboRoMrH3MweB7WH_4zupdTDa39LtLcOZUF-3V752C1Xz2Wj8Vi-Xjc_2wKDSpeCoqgo2RVkhHNHGYUbOWpFTcGKKQXDsknBCsQnhdOiWRFog6xSljVBliXEWn4PbQuw3-c7QxNX0bte06NVg_xoYwwnlZyVJk9OYI3fgxDPm7TDFWClFylil0oHTwMQbrmm1oexV2DUbNfufmeOccKQ6RqN7tX-m__A80onux</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2444866854</pqid></control><display><type>article</type><title>Patient Factors Lead to Extensive Variation in Outcomes and Cost From Cholecystectomy</title><source>SAGE Complete</source><creator>Baimas-George, Maria ; Kirks, Russell C. ; Cochran, Allyson ; Baker, Erin H. ; Lauren Paton, B. ; Schiffern, Lynnette M. ; Matthews, Brent D. ; Martinie, John B. ; Vrochides, Dionisios ; Iannitti, David A.</creator><creatorcontrib>Baimas-George, Maria ; Kirks, Russell C. ; Cochran, Allyson ; Baker, Erin H. ; Lauren Paton, B. ; Schiffern, Lynnette M. ; Matthews, Brent D. ; Martinie, John B. ; Vrochides, Dionisios ; Iannitti, David A.</creatorcontrib><description>Background
Cholecystectomy is a common procedure with significantly varied outcomes. We analyzed differences in comorbidities, outcomes, and cost of cholecystectomy by acute care surgery (ACS) versus hepatopancreaticobiliary (HPB) surgery.
Study design
Patients were retrospectively identified between 2008 and 2015. Exclusion criteria included the following: (1) part of another procedure; (2) abdominal trauma; (3) ICU admission; vasopressors.
Results
One hundred and twenty-six ACS and 122 HPB patients were analyzed. The HPB subset had higher burden of comorbid disease and significantly lower projected 10-year survival (87.4% ACS vs 68.5% HPB, P < .0001). Median lengths of stay were longer in HPB patients (2 vs 5 days, P < .0001) as were readmission rates (30-day 5.6% vs 13.1%, P = .040; 90-day 7.9% vs 20.5%, P = .005). Median cost was higher including operative supply cost ($969.42 vs $1920.66, P < .0001) and total cost of care ($7340.66 vs $19 338.05, P < .0001). A predictive scoring system for difficult gallbladders was constructed and a phone application was created.
Conclusion
Cholecystectomy in a complicated patient can be difficult with longer hospital stays and higher costs. The utilization of procedure codes to explain disparities is not sufficient. Incorporation of comorbidities needs to be addressed for planning and reimbursement.</description><identifier>ISSN: 0003-1348</identifier><identifier>EISSN: 1555-9823</identifier><identifier>DOI: 10.1177/0003134820923311</identifier><language>eng</language><publisher>Los Angeles, CA: SAGE Publications</publisher><subject>Alcohol use ; Cholecystectomy ; Comorbidity ; Cost analysis ; Costs ; Datasets ; Diabetes ; Gallbladder ; Hospitals ; Laparoscopy ; Liver diseases ; Mortality ; Patients ; Statistical analysis ; Surgeons ; Surgery ; Trauma ; Variables</subject><ispartof>The American surgeon, 2020-06, Vol.86 (6), p.643-651</ispartof><rights>The Author(s) 2020</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c295t-921dd7e67f2c2f143db728a5dd2a07bf06f664901b8fa70c603fa53443ad2df93</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://journals.sagepub.com/doi/pdf/10.1177/0003134820923311$$EPDF$$P50$$Gsage$$H</linktopdf><linktohtml>$$Uhttps://journals.sagepub.com/doi/10.1177/0003134820923311$$EHTML$$P50$$Gsage$$H</linktohtml><link.rule.ids>314,776,780,21798,27901,27902,43597,43598</link.rule.ids></links><search><creatorcontrib>Baimas-George, Maria</creatorcontrib><creatorcontrib>Kirks, Russell C.</creatorcontrib><creatorcontrib>Cochran, Allyson</creatorcontrib><creatorcontrib>Baker, Erin H.</creatorcontrib><creatorcontrib>Lauren Paton, B.</creatorcontrib><creatorcontrib>Schiffern, Lynnette M.</creatorcontrib><creatorcontrib>Matthews, Brent D.</creatorcontrib><creatorcontrib>Martinie, John B.</creatorcontrib><creatorcontrib>Vrochides, Dionisios</creatorcontrib><creatorcontrib>Iannitti, David A.</creatorcontrib><title>Patient Factors Lead to Extensive Variation in Outcomes and Cost From Cholecystectomy</title><title>The American surgeon</title><description>Background
Cholecystectomy is a common procedure with significantly varied outcomes. We analyzed differences in comorbidities, outcomes, and cost of cholecystectomy by acute care surgery (ACS) versus hepatopancreaticobiliary (HPB) surgery.
Study design
Patients were retrospectively identified between 2008 and 2015. Exclusion criteria included the following: (1) part of another procedure; (2) abdominal trauma; (3) ICU admission; vasopressors.
Results
One hundred and twenty-six ACS and 122 HPB patients were analyzed. The HPB subset had higher burden of comorbid disease and significantly lower projected 10-year survival (87.4% ACS vs 68.5% HPB, P < .0001). Median lengths of stay were longer in HPB patients (2 vs 5 days, P < .0001) as were readmission rates (30-day 5.6% vs 13.1%, P = .040; 90-day 7.9% vs 20.5%, P = .005). Median cost was higher including operative supply cost ($969.42 vs $1920.66, P < .0001) and total cost of care ($7340.66 vs $19 338.05, P < .0001). A predictive scoring system for difficult gallbladders was constructed and a phone application was created.
Conclusion
Cholecystectomy in a complicated patient can be difficult with longer hospital stays and higher costs. The utilization of procedure codes to explain disparities is not sufficient. Incorporation of comorbidities needs to be addressed for planning and reimbursement.</description><subject>Alcohol use</subject><subject>Cholecystectomy</subject><subject>Comorbidity</subject><subject>Cost analysis</subject><subject>Costs</subject><subject>Datasets</subject><subject>Diabetes</subject><subject>Gallbladder</subject><subject>Hospitals</subject><subject>Laparoscopy</subject><subject>Liver diseases</subject><subject>Mortality</subject><subject>Patients</subject><subject>Statistical analysis</subject><subject>Surgeons</subject><subject>Surgery</subject><subject>Trauma</subject><subject>Variables</subject><issn>0003-1348</issn><issn>1555-9823</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>8G5</sourceid><sourceid>BENPR</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNp1kE1LAzEYhIMoWKt3jwEvXlbznd2jLK0KhXqwXpc0H7pld1OTrNh_b0oFoeDpZZhnhpcB4BqjO4ylvEcIUUxZSVBFKMX4BEww57yoSkJPwWRvF3v_HFzEuMmSCY4nYPWiUmuHBOdKJx8iXFhlYPJw9p3sENsvC99UaDPkB9gOcDkm7XsboRoMrH3MweB7WH_4zupdTDa39LtLcOZUF-3V752C1Xz2Wj8Vi-Xjc_2wKDSpeCoqgo2RVkhHNHGYUbOWpFTcGKKQXDsknBCsQnhdOiWRFog6xSljVBliXEWn4PbQuw3-c7QxNX0bte06NVg_xoYwwnlZyVJk9OYI3fgxDPm7TDFWClFylil0oHTwMQbrmm1oexV2DUbNfufmeOccKQ6RqN7tX-m__A80onux</recordid><startdate>202006</startdate><enddate>202006</enddate><creator>Baimas-George, Maria</creator><creator>Kirks, Russell C.</creator><creator>Cochran, Allyson</creator><creator>Baker, Erin H.</creator><creator>Lauren Paton, B.</creator><creator>Schiffern, Lynnette M.</creator><creator>Matthews, Brent D.</creator><creator>Martinie, John B.</creator><creator>Vrochides, Dionisios</creator><creator>Iannitti, David A.</creator><general>SAGE Publications</general><general>SAGE PUBLICATIONS, INC</general><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>4T-</scope><scope>4U-</scope><scope>7QL</scope><scope>7RV</scope><scope>7T7</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88I</scope><scope>8AF</scope><scope>8AO</scope><scope>8FD</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9-</scope><scope>K9.</scope><scope>KB0</scope><scope>M0R</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>M2P</scope><scope>M7N</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>P64</scope><scope>PHGZM</scope><scope>PHGZT</scope><scope>PJZUB</scope><scope>PKEHL</scope><scope>PPXIY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>S0X</scope><scope>7X8</scope></search><sort><creationdate>202006</creationdate><title>Patient Factors Lead to Extensive Variation in Outcomes and Cost From Cholecystectomy</title><author>Baimas-George, Maria ; Kirks, Russell C. ; Cochran, Allyson ; Baker, Erin H. ; Lauren Paton, B. ; Schiffern, Lynnette M. ; Matthews, Brent D. ; Martinie, John B. ; Vrochides, Dionisios ; Iannitti, David A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c295t-921dd7e67f2c2f143db728a5dd2a07bf06f664901b8fa70c603fa53443ad2df93</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Alcohol use</topic><topic>Cholecystectomy</topic><topic>Comorbidity</topic><topic>Cost analysis</topic><topic>Costs</topic><topic>Datasets</topic><topic>Diabetes</topic><topic>Gallbladder</topic><topic>Hospitals</topic><topic>Laparoscopy</topic><topic>Liver diseases</topic><topic>Mortality</topic><topic>Patients</topic><topic>Statistical analysis</topic><topic>Surgeons</topic><topic>Surgery</topic><topic>Trauma</topic><topic>Variables</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Baimas-George, Maria</creatorcontrib><creatorcontrib>Kirks, Russell C.</creatorcontrib><creatorcontrib>Cochran, Allyson</creatorcontrib><creatorcontrib>Baker, Erin H.</creatorcontrib><creatorcontrib>Lauren Paton, B.</creatorcontrib><creatorcontrib>Schiffern, Lynnette M.</creatorcontrib><creatorcontrib>Matthews, Brent D.</creatorcontrib><creatorcontrib>Martinie, John B.</creatorcontrib><creatorcontrib>Vrochides, Dionisios</creatorcontrib><creatorcontrib>Iannitti, David A.</creatorcontrib><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Docstoc</collection><collection>University Readers</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Nursing & Allied Health Database</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Virology and AIDS Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>STEM Database</collection><collection>ProQuest Pharma Collection</collection><collection>Technology Research Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Consumer Health Database</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Science Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Research Library (Corporate)</collection><collection>Nursing & Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest Central (New)</collection><collection>ProQuest One Academic (New)</collection><collection>ProQuest Health & Medical Research Collection</collection><collection>ProQuest One Academic Middle East (New)</collection><collection>ProQuest One Health & Nursing</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>SIRS Editorial</collection><collection>MEDLINE - Academic</collection><jtitle>The American surgeon</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Baimas-George, Maria</au><au>Kirks, Russell C.</au><au>Cochran, Allyson</au><au>Baker, Erin H.</au><au>Lauren Paton, B.</au><au>Schiffern, Lynnette M.</au><au>Matthews, Brent D.</au><au>Martinie, John B.</au><au>Vrochides, Dionisios</au><au>Iannitti, David A.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Patient Factors Lead to Extensive Variation in Outcomes and Cost From Cholecystectomy</atitle><jtitle>The American surgeon</jtitle><date>2020-06</date><risdate>2020</risdate><volume>86</volume><issue>6</issue><spage>643</spage><epage>651</epage><pages>643-651</pages><issn>0003-1348</issn><eissn>1555-9823</eissn><abstract>Background
Cholecystectomy is a common procedure with significantly varied outcomes. We analyzed differences in comorbidities, outcomes, and cost of cholecystectomy by acute care surgery (ACS) versus hepatopancreaticobiliary (HPB) surgery.
Study design
Patients were retrospectively identified between 2008 and 2015. Exclusion criteria included the following: (1) part of another procedure; (2) abdominal trauma; (3) ICU admission; vasopressors.
Results
One hundred and twenty-six ACS and 122 HPB patients were analyzed. The HPB subset had higher burden of comorbid disease and significantly lower projected 10-year survival (87.4% ACS vs 68.5% HPB, P < .0001). Median lengths of stay were longer in HPB patients (2 vs 5 days, P < .0001) as were readmission rates (30-day 5.6% vs 13.1%, P = .040; 90-day 7.9% vs 20.5%, P = .005). Median cost was higher including operative supply cost ($969.42 vs $1920.66, P < .0001) and total cost of care ($7340.66 vs $19 338.05, P < .0001). A predictive scoring system for difficult gallbladders was constructed and a phone application was created.
Conclusion
Cholecystectomy in a complicated patient can be difficult with longer hospital stays and higher costs. The utilization of procedure codes to explain disparities is not sufficient. Incorporation of comorbidities needs to be addressed for planning and reimbursement.</abstract><cop>Los Angeles, CA</cop><pub>SAGE Publications</pub><doi>10.1177/0003134820923311</doi><tpages>9</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0003-1348 |
ispartof | The American surgeon, 2020-06, Vol.86 (6), p.643-651 |
issn | 0003-1348 1555-9823 |
language | eng |
recordid | cdi_proquest_miscellaneous_2425589786 |
source | SAGE Complete |
subjects | Alcohol use Cholecystectomy Comorbidity Cost analysis Costs Datasets Diabetes Gallbladder Hospitals Laparoscopy Liver diseases Mortality Patients Statistical analysis Surgeons Surgery Trauma Variables |
title | Patient Factors Lead to Extensive Variation in Outcomes and Cost From Cholecystectomy |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-21T19%3A23%3A07IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Patient%20Factors%20Lead%20to%20Extensive%20Variation%20in%20Outcomes%20and%20Cost%20From%20Cholecystectomy&rft.jtitle=The%20American%20surgeon&rft.au=Baimas-George,%20Maria&rft.date=2020-06&rft.volume=86&rft.issue=6&rft.spage=643&rft.epage=651&rft.pages=643-651&rft.issn=0003-1348&rft.eissn=1555-9823&rft_id=info:doi/10.1177/0003134820923311&rft_dat=%3Cproquest_cross%3E2444866854%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2444866854&rft_id=info:pmid/&rft_sage_id=10.1177_0003134820923311&rfr_iscdi=true |